- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Paroxysmal nocturnal hemoglobinuria (PNH)
- Meeting Date: July 2024
- Public Summary Document (PSD) July 2024 PBAC Meeting - (PDF 840KB)
- Public Summary Document (PSD) July 2024 PBAC Meeting - (Word 215KB)
Iptacopan – July 2024
Iptacopan; Capsule 200 mg; Fabhalta®
Last updated
30 May 2025